Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-04 4:31 pm Purchase | 2024-11-27 | 13G | InspireMD, Inc. NSPR | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 1,411,636 5.220% | 1,411,636 (New Position) | Filing History |
| 2024-11-14 6:35 pm Unchanged | 2024-09-30 | 13G | InspireMD, Inc. NSPR | ORBIMED ADVISORS LLC | 2,133,405 8.300% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | InspireMD, Inc. NSPR | Nantahala Capital Management LLC | 2,607,884 9.990% | 445,492 (+20.60%) | Filing History |
| 2024-10-28 4:02 pm Unchanged | 2024-09-30 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors, Inc. | 7,438,181 9.800% | 0 (Unchanged) | Filing History |
| 2024-07-11 5:48 pm Sale | 2024-06-28 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors, Inc. | 7,438,181 9.900% | -21,747 (-0.29%) | Filing History |
| 2024-05-17 12:58 pm Sale | 2024-04-24 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors, Inc. | 7,459,928 9.900% | -1,528,390 (-17.00%) | Filing History |
| 2024-04-25 7:30 pm Unchanged | 2024-03-31 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors, Inc. | 8,988,318 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 9:33 pm Unchanged | 2023-12-31 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors, Inc. | 8,988,318 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 7:41 pm Purchase | 2023-12-31 | 13G | InspireMD, Inc. NSPR | ORBIMED ADVISORS LLC | 2,133,405 9.900% | 2,133,405 (New Position) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | InspireMD, Inc. NSPR | Nantahala Capital Management LLC | 2,162,392 9.900% | 2,162,392 (New Position) | Filing History |
| 2023-06-16 4:15 pm Purchase | 2023-06-08 | 13D | InspireMD, Inc. NSPR | Shore Craig | 1,700,159 8.010% | 1,700,159 (New Position) | Filing History |
| 2023-06-07 5:33 pm Purchase | 2023-06-01 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors, Inc. | 8,988,318 9.900% | 8,988,318 (New Position) | Filing History |
| 2023-05-24 4:31 pm Purchase | 2023-05-16 | 13G | InspireMD, Inc. NSPR | Soleus Private Equity Fund III L.P. | 2,199,118 9.900% | 2,199,118 (New Position) | Filing History |
| 2023-05-22 4:15 pm Purchase | 2023-05-12 | 13G | InspireMD, Inc. NSPR | Marshall Wace North America L.P. | 1,860,405 9.900% | 1,860,405 (New Position) | Filing History |
| 2022-02-11 5:04 pm Purchase | 2021-12-31 | 13G | InspireMD, Inc. NSPR | Lind Global Macro Fund LP | 177,333 2.100% | 177,333 (New Position) | Filing History |
| 2021-02-09 5:00 pm Sale | 2020-12-31 | 13G | InspireMD, Inc. NSPR | Lind Global Macro Fund LP | 137,011 5.300% | -125,868 (-47.88%) | Filing History |
| 2021-01-29 06:58 am Purchase | 2020-12-31 | 13G | InspireMD, Inc. NSPR | Mitchell P. Kopin | 96,511 3.800% | 70,070 (+265.00%) | Filing History |
| 2021-01-08 09:37 am Purchase | 2020-12-31 | 13G | InspireMD, Inc. NSPR | SABBY MANAGEMENT, LLC | 122,936 11.000% | 98,741 (+408.11%) | Filing History |
| 2020-06-19 11:36 am Sale | 2020-06-05 | 13G | InspireMD, Inc. NSPR | L1 Capital Global Opportunities Master Fund, Ltd. | 43,619 4.990% | -36,292 (-45.42%) | Filing History |
| 2020-06-10 12:26 pm Purchase | 2020-06-03 | 13G | InspireMD, Inc. NSPR | L1 Capital Global Opportunities Master Fund, Ltd. | 79,911 9.990% | 79,911 (New Position) | Filing History |